Genomoncology pathology workbench to support omniseq insight℠, a genomic and immune profiling test that identifies potential treatment and clinical trial options for solid tumors

Cleveland, jan. 12, 2022 /prnewswire/ -- genomoncology announced today that genomoncology (go) pathology workbench has been selected by labcorp's omniseq to support the analysis and reporting of omniseq insight℠, a comprehensive genomic and immune profiling test for solid tumors. omniseq insight combines genomic and immune profiling to comprehensively characterize a patient's tumor to identify potential treatment and clinical trial options.
LH Ratings Summary
LH Quant Ranking